ACADIA PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Acadia Pharmaceuticals Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Acadia Pharmaceuticals Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 166M shares, a 1.53% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 166M +2.5M +1.53% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 165M +2.58M +1.59% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 165M +2.59M +1.6% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 164M +2.1M +1.3% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 163M +1.51M +0.94% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 162M +1M +0.62% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 162M +1.05M +0.65% Dec 31, 2022 10-K 2024-02-28
Q3 2022 162M +1.18M +0.74% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 162M +1.22M +0.76% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 161M +1.21M +0.76% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 161M +1.37M +0.86% Dec 31, 2021 10-K 2023-02-28
Q3 2021 161M +1.83M +1.15% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 161M +3.24M +2.06% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 160M +4.73M +3.04% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 160M +4.36M +2.81% Dec 31, 2020 10-K 2022-03-01
Q3 2020 159M +5.32M +3.47% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 157M +12.9M +8.95% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 155M +11.3M +7.85% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 155M +11.4M +7.94% Dec 31, 2019 10-K 2021-02-25
Q3 2019 154M +28.5M +22.8% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 144M +19.5M +15.6% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 144M +19.3M +15.5% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 144M +19.4M +15.6% Dec 31, 2018 10-K 2020-02-27
Q3 2018 125M +2.31M +1.88% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 125M +2.66M +2.18% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 125M +2.81M +2.31% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 124M +3.04M +2.51% Dec 31, 2017 10-K 2019-02-27
Q3 2017 123M +1.61M +1.33% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 122M +8.65M +7.61% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 122M +9.21M +8.17% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 121M +19.4M +19.1% Dec 31, 2016 10-K 2018-02-27
Q3 2016 121M +20.2M +20% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 114M +13.2M +13.1% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 113M +12.5M +12.5% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 102M +1.89M +1.89% Dec 31, 2015 10-K 2017-02-28
Q3 2015 101M +1.19M +1.2% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 101M +1.22M +1.23% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 100M +1.45M +1.46% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 100M +8.94M +9.82% Dec 31, 2014 10-K 2016-02-29
Q3 2014 99.7M +10.7M +12.1% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 99.3M +15.9M +19% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 98.8M +25.4M +34.6% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 91.1M +17.8M +24.2% Dec 31, 2013 10-K 2015-02-26
Q3 2013 89M +32.4M +57.2% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 83.4M +30.4M +57.3% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 73.5M +20.5M +38.8% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 73.3M +20.4M +38.6% Dec 31, 2012 10-K 2014-02-27
Q3 2012 56.6M +3.79M +7.18% Sep 30, 2012 10-Q 2012-11-05
Q2 2012 53M +230K +0.44% Jun 30, 2012 10-Q 2012-08-08
Q1 2012 52.9M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 52.9M +13.5M +34.4% Dec 31, 2011 10-K 2013-03-12
Q3 2011 52.8M Sep 30, 2011 10-Q 2011-11-09
Q2 2011 52.8M Jun 30, 2011 10-Q 2011-08-10
Q4 2010 39.4M Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.